June 14, 2018
Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site
Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
June 13, 2018
TiGenix’s CEO leaves as operations integrate into Takeda
TiGenix NV’s Chief Executive Officer, Eduardo Bravo will depart the board of directors and his role as CEO of TiGenix…
June 13, 2018
4D cleared to study Blautix, its Irritable Bowel Syndrome treatment in UK and Ireland
4D pharma has been cleared by the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Products Regulatory Authority…
June 13, 2018
Santhera Pharmaceuticals submits NDA in South Korea for Raxone for the treatment of LHON
Santhera Pharmaceuticals said on Tuesday that the Korean Ministry of Food and Drug Safety (MFDS) has accepted its new drug…
June 12, 2018
Alvogen, Pfenex in a US marketed osteoporosis drug commercialization deal
Alvogen and Pfenex have signed a deal which grants Alvogen exclusive rights to commercialize Pfenex’s lead drug candidate, PF708, a…
June 12, 2018
FDA grants Fast Track designation in the US for Nordic Nanovector’s Follicular Lymphoma drug
The US Food & Drug Administration (FDA) has granted Fast Track designation to Nordic Nanovector’s Betalutin (177Lu-lilotomab satetraxetan) for the treatment of…
June 7, 2018
Bayer closes Monsanto acquisition
Bayer successfully completed the acquisition of Monsanto on Thursday. Shares in the U.S. company will no longer be traded on the…
June 7, 2018
BioMarin bags $20 million in milestone payments
BioMarin Pharmaceutical has received $20 million in milestone payments from Pfizer Inc, it said Thursday.
June 7, 2018
Merck, 4D evaluating Keytruda + 4D’s oncology programme for patients with solid tumours
A clinical stage biopharmaceutical company, 4D pharma, pioneering the development of Live Biotherapeutic Products, has made a deal with a subsidiary of…
June 7, 2018
Study findings on mineral excipient for enhanced ODTs
In a recent study, scientists confirmed the ability of Omyapharm to formulate orally disintegrating tablets (ODTs) with enhanced mouthfeel and…